The RDH10 gene helps your body turn vitamin A into a form used to make retinoic acid, a key signal for early growth and organ development. This gene plays an important role in guiding how the eyes, face, limbs, and other tissues form before birth. If the gene does not work properly, a baby may develop with differences in these areas, and some children may also have growth or developmental challenges. RDH10 is mainly discussed in rare genetic conditions rather than popular culture.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do the work. Other genes mainly help regulate when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. If you want to explore this topic in greater detail, you can learn more in the LearnHub.
Overview
RDH10Gene function
What if the gene works
The RDH10 gene helps your body convert vitamin A into retinal, an early step in making retinoic acid. This signal supports normal growth and the development of the face, limbs, eyes, and other organs before birth.
Risk
What if the gene does not work
Biallelic variants in the RDH10 gene can disrupt vitamin A signaling in early development, causing birth differences that often affect the eyes, face, heart, and limbs. Milder and severe variants may change which features appear and how marked they are.
Treatment
What does that mean for your treatment
For pathogenic variants in the RDH10 gene, no RDH10-specific treatment or drug selection approach is currently established in clinical guidelines. Research is exploring how the RDH10 gene affects vitamin A signaling, but this has not led to a guideline-based therapy.
Gene function
What if the gene works
Your body uses the RDH10 gene to process vitamin A in a careful, stepwise way. It helps convert retinol, a form of vitamin A from food, into retinaldehyde, the next form needed to make retinoic acid. Understanding how the RDH10 gene helps process vitamin A makes it easier to see how cells get signals for normal growth and everyday tissue upkeep.
The RDH10 gene helps cells convert retinol, a form of vitamin A, into retinaldehyde. This is the key first step that starts retinoic acid production.
Retinaldehyde made through the RDH10 gene can then be turned into retinoic acid, a vitamin A signal. This signal helps control when certain genes turn on or off.
Many tissues use the RDH10 gene to make vitamin A signals where they are needed. This helps nearby cells respond in a more precise, organized way.
During embryonic growth, vitamin A signals supported by the RDH10 gene help guide body patterning and organ formation. These signals act like timing and position cues for developing tissues.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. Variants like this are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many do not produce any noticeable effect and are simply part of natural genetic variation. In some instances, though, a variant changes how a gene functions more significantly and can contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
RDH10 gene variants can change the enzyme’s shape, stability, or ability to bind vitamin A, so cells make less retinal, the step needed to produce retinoic acid. In discussions of how RDH10 gene variants affect protein function, milder variants may leave some enzyme activity, while more severe variants can greatly reduce or abolish it. Variants that disrupt where the protein sits in the cell can also weaken this pathway.
How variants are linked to conditions
Pathogenic variants in both copies of the RDH10 gene can cause a rare inherited condition often described as syndromic microphthalmia, an RDH10 gene condition linked to small eyes or other eye differences. Reported features can also include growth delay, distinctive facial features, and genital or skeletal differences, although the pattern varies from person to person. Because this is a monogenic condition, finding two disease-causing variants in the RDH10 gene can help confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RDH10 gene itself. Risk is mainly shaped by whether someone has a disease-causing change in RDH10 and, in inherited conditions, whether it was passed down from one or both parents.
Inheritance of RDH10 variants
RDH10-related conditions are inherited in an autosomal recessive pattern. For families asking about RDH10 gene inheritance, this usually means a person has to inherit one changed copy of the RDH10 gene from each parent to be affected. Parents who each carry one variant in the RDH10 gene are often unaffected themselves, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without the familial variant.
What does my RDH10 result mean for my family?
When an RDH10 result is tied to a known inherited condition, it is usually passed down in a recessive pattern. For families, this often means parents are healthy carriers, brothers and sisters may also be carriers or may have the condition, and relatives on both sides of the family could carry the same gene change. This can matter for family planning and for understanding whether the result may also be present in close relatives.
Genetic information
Genetic testing
How you find out about variants
Variants in the RDH10 gene are found through genetic testing, usually on a blood or saliva sample that a lab checks for changes in your DNA. RDH10 genetic testing may be part of a test that checks several genes at once for an inherited condition. Results may identify a linked variant, an unclear finding, or no relevant variant.
When should I consider getting a genetic test?
Genetic testing for the RDH10 gene may be considered when a baby or child has major eye development differences from birth, especially if there are also other birth differences or a family history of a similar pattern. Testing can help show whether an RDH10-related condition is the cause.
A genetic result is only one part of your health story
A genetic result may provide useful insight, but how much it can tell you depends on the condition and the specific type of variant involved. Other factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medications. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body breaks it down and handles it. This understanding can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the RDH10 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about side effects, new symptoms, or how medicines may work for you are best discussed with your doctor.
History
Research on the RDH10 gene grew out of broader efforts to understand how vitamin A is handled during early development. In the early 2000s, scientists identified RDH10 as a distinct human gene after related enzymes had already been described in animals and other tissues. From these first observations, research expanded steadily, especially when mouse studies showed that changes in RDH10 were linked to major differences in embryo formation. Those findings made RDH10 important in developmental genetics because they connected an individual gene to early body patterning in a clear way. Later studies in people linked rare RDH10 variants to inherited conditions affecting growth and development, which strengthened its place in medical genetics. Today, RDH10 is best known in research as part of the path from basic developmental biology to clinical gene discovery.